Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer
NCT ID: NCT01345760
Last Updated: 2012-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2008-07-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expression Levels of microRNA Processing Enzymes Dicer and Drosha in Epithelial Skin Cancer
NCT00849914
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
NCT01444560
Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi
NCT00862914
Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma
NCT01500954
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Basal Cell Carcinoma
No interventions assigned to this group
Squamous Cell Carcinoma
No interventions assigned to this group
Actinic Keratosis
No interventions assigned to this group
healthy non-lesional skin
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Sand
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Falk G Bechara, PD Dr.
Role: STUDY_DIRECTOR
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-Sand
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.